Clinical Trial Update: Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

View source ↗

Summary

A completed clinical trial conducted at MD Anderson evaluated quality of life in patients with acute myeloid leukemia or myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Status: COMPLETED